As an undergraduate, many years ago when I was young and daring, I volunteered to take part in a psychological test. “Volunteered” may not be the correct term, since the deal was that I would get paid ten bucks for about two hours of my time, which was a princely wage when most jobs that […]
Articles
Chris Wood at RiskHedge is selling one of his higher-end newsletters, Project 5X ($2,497 for the first year, 30-day refund period), by teasing that he will reveal “My #1 Play of the Psychedelic Medicine Revolution”… largely because, like many pundits, he believes that psychedelic drugs might follow the path worn by marijuana over the past […]
This Green Chip Stocks teaser pitch began life as a pitch for “Magic Molecule” stocks that will “change everything” and cure alcoholism, depression, PTSD and so much more… that original ad, which we covered on June 22, has now been updated a bit and is going out under the “Molecule 520” headline, but still hinting […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
I have a ton of conviction that many of these psychedelics will provide clinically significant advances in depression, P...
I believe it is only a matter of time before the good companies in psychedelics take off.There is too much evidence the...
I have a holding with M2Bio Biosciences - currently known as Wuhan General - pending a badly needed name change. Th...
Hi this round is definitely still open. It’s only about 1/3 funded. I get auto-invitations to invest from the founder ...
I received a snail mail circular a couple weeks ago (gah, they come by post too) pitching CLABF but I can't recollect ...
Mydecine (MYCOF). Valuation: $94M. Pipeline: Phase 2A clinical on PTSD and smoking cessation. Molecule: pure psilocybin ...
Numinus (LKYSF). Valuation: $168M. Pipeline: Phase 1 to assess the safety and psychoactive properties of a Psilocybe mus...
Cybin (CLXPF). Valuation: $440M. Pipeline: Pre-clinical to Phase 2 for Alcohol Abuse, Psychiatric and Neurologic Disorde...
Compass (CMPS). Valuation: $1.4B. Pipeline: Pre-clinical to Phase 2(b) for Treatment Resitant (TRD). Molecule: Psilocybi...
Ei.ventures. Valuation: Pre-IPO, in the process of raising capital $50M. Pipeline: None. Molecule: Natural psilocybin ex...
Here's 4 companies from Teeka you you might want to consider for your high risk high reward investing style. Cybin (CL...
Thank you for this information glove77. ei.ventures is engaged in psilocybin mushroom extract and mushroom based nutrit...
I listened to part of the presentation, which was mostly due to there being so much hype, and I didn't want to give it t...
My wife's walking buddy said I should look at Mind Medicine, at $3/share it would be easy to get into. With Oregon l...
On Nov. 3rd, my home state, Oregon, became the first to legalize psilocybin therapy with the passage of Measure 109. Or...
Micro Dossing Powdering your dried psilocybin mushrooms is by far the best way to yield the most consistent psilocybin m...
Where's the discussion about Magic Mushrooms? I've kind of researched the topic. Have I posted that Pharma wants to prof...